Complete blood count |
Hemoglobin |
Important in evaluating anemia |
May be abnormal in HSCT |
It is not a good biochemistry parameter for children undergoing HSCT, if used in isolation |
Must be monitored to optimize high-protein food supply |
Leukocytes |
Defense cells of the body |
Abnormal until total recovery of the bone marrow |
Indicator for introduction of dietary restrictions for potentially contaminated foods (e.g. no raw food) when counts are below 1.500/mm³ |
Neutrophils |
Primary defense cells, mainly in bacterial infections |
Abnormal until full blood marrow recovery or during drug treatment |
Indicator for introduction of dietary restrictions for potentially contaminated foods (e.g., no raw food) when counts are below 500/mm³ |
Platelets |
Takes part in the blood coagulation process |
Abnormal until total recovery of the bone marrow |
When below the reference value, caution is advised when indicating urinary catheter due to the risk of bleeding, and when assessing body composition |
Liver function |
Transaminases |
Liver function test parameter |
Usually abnormal during HSCT |
Monitor variations and, if necessary, control consumption of fat-rich foods and preparations |
Bilirubin |
Indicator of liver abnormalities |
If increased, it can be indicative of hepatocellular damage |
Monitor variations and, if necessary, control consumption of fat-rich foods and preparations |
Kidney function |
Creatinine |
Indicator of kidney function abnormalities |
May be increased in situations of prolonged hydration deprivation |
Monitor tests and optimize water supply |
Urea |
May be an indicator of hydration status |
Increased in cases of dehydration or excessive protein catabolism and decreased in hyper-hydration or malnutrition |
Monitor tests and water supply |
Sodium |
If increased, it is suggestive of low water intake or dehydration and, if decreased, it may be suggestive of edema |
Follow up hydration tests and perform anthropometric assessment |
Potassium |
Assists in evaluating kidney function |
Abnormal values can require optimization or restriction of potassium-rich food consumption |
Lipid profile |
Total cholesterol |
Can be abnormal due to drugs or changes in dietary intake |
Monitor tests and adapt diet |
Triglycerides |
May be abnormal after changes in eating habits or use of drugs. For patients on parenteral therapy, it can be used to evaluate lipid supply and to assess the onset and progression of infusion rates |
Blood glucose |
|
May be abnormal if corticosteroids are used, leading to hyperglycemia |
Patients may present with hypoglycemia after long fasting periods |
Perform longitudinal follow-up and limit refined sugar in diet |